Drug
Relenopride clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2012
How studies write it
Studies that test it under each name
Development codes
- YKP10811
- 1
Studies by the year they started
3 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2013 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses relenopride is read from its arms, and is right about nine times in ten.
Testing it · 3
- Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With ConstipationCompletedPhase 2SK Chemicals Co., Ltd.NCT02082457Written as YKP10811 5mg
- A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic ConstipationCompletedPhase 2SK Life Science, Inc.NCT01989234Written as YKP10811
- A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional ConstipationCompletedPhase 2SK Life Science, Inc.NCT01523184Written as YKP10811 Drug Product Capsule
Codes
What other systems call relenopride · ClinicalTrials.gg INT000286
- UNII (FDA) SIS5BFO4WLRELENOPRIDEConfirmed FDA, Wikidata
- Wikidata Q27088530relenoprideConfirmed FDA, Wikidata
- NCI Thesaurus C152177RelenoprideOne source FDA
- DrugBank DB12798One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | SIS5BFO4WL | RELENOPRIDE | Confirmed FDA, Wikidata |
| Wikidata | Q27088530 | relenopride | Confirmed FDA, Wikidata |
| NCI Thesaurus | C152177 | Relenopride | One source FDA |
| DrugBank | DB12798 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.